| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Feb―11 |
Patient engagement with home blood pressure monitoring - cannot have been properly assessed during the pandemic |
Julian Eek Mariampillai, Camilla Lund Søraas, Sverre E. Kjeldsen |
| 2 |
[GO] |
2025―Apr―17 |
Higher blood pressure variability during hospitalization is associated with lower cerebral white matter integrity in COVID-19 patients |
Theresa J van Lith, Esther Janssen, Jan-Willem van Dalen, Hao Li, Mats Koeneman, Wouter M Sluis, Naomi T Wijers, Marieke JH Wermer, Menno V Huisman, H. Bart van der Worp, Frederick JA Meijer, Anil M Tuladhar, Sebastian JH Bredie, Frank-Erik de Leeuw |
| 3 |
[GO] |
2023―Jan―25 |
Ambulatory blood pressure monitoring in treated patients with hypertension in the COVID-19 pandemic - The study of European society of hypertension (ESH ABPM COVID-19 study) |
Wiktoria Wojciechowska, Marek Rajzer, Thomas Weber, Aleksander Prejbisz, Piotr Dobrowolski, Aleksandra Ostrowska, Grzegorz Bilo, Giuseppe Mancia, Reinhold Kreutz, Andrzej Januszewicz |
| 4 |
[GO] |
2022―May―12 |
Soluble ACE2 and angiotensin II levels are modulated in hypertensive COVID-19 patients treated with different antihypertension drugs |
Mohamed A. Elrayess, Hadeel T. Zedan, Rand A. Alattar, Hatem Abusriwil, Mahmoud Khatib A. A. Al-Ruweidi, Shamma Almuraikhy, Jabeed Parengal, Bassem Alhariri, Hadi M. Yassine, Ali A. Hssain, Arun Nair, Musaed Al Samawi, Alaaeldin Abdelmajid, Jassim Al Suwaidi, Mohamed Omar Saad, Muna Al-Maslamani, Ali S. Omrani, Huseyin C. Yalcin |
| 5 |
[GO] |
2022―Apr―23 |
Covid-19 associated reduction in hypertension-related diagnostic and therapeutic procedures in Excellence Centers of the European Society of Hypertension |
Thomas Weber, Jaques Amar, Tine de Backer, Thilo Burkard, Marcus van der Giet, Philippe Gosse, Andrzej Januszewicz, Thomas Kahan, Giuseppe Mancia, Christopher C. Mayer, Maria Lorenza Muiesan, George S. Stergiou, Konstantinos Tsioufis, Bernard Vaisse, Reinhold Kreutz |
| 6 |
[GO] |
2022―Apr―15 |
Hypertension management during the COVID-19 pandemic: what can we learn for the future? |
Michel Burnier, Sverre E. Kjeldsen, Krzysztof Narkiewicz, Brent Egan, Reinhold Kreutz |
| 7 |
[GO] |
2020―Dec―22 |
Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers |
Sverre E. Kjeldsen, Krzysztof Narkiewicz, Michel Burnier, Suzanne Oparil |
|
